News

SoloPath is a percutaneous transseptal access catheter based on the company's Controlled Deployment Technology (CDT).  The platform allows the "introduction of a dimensionally small catheter to a specific site, which once positioned, can be radially expanded to deploy a semi-rigid sheath to maintain access to the treatment site."

The SoloPath technology allows cardiologists  a novel approach to access the left atrium and pulmonary veins through the atrial septum, for treatment of such conditions as atrial fibrillation.